New York State Common Retirement Fund
LPCN icon

New York State Common Retirement Fund’s Lipocine LPCN Stock Holding History

New York State Common Retirement Fund’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,006
Closed -$67K – 3213
2017
Q1 		$67K Hold
1,006
– – ﹤0.01% 3031
2016
Q4 		$63K Hold
1,006
– – ﹤0.01% 3032
2016
Q3 		$76K Hold
1,006
– – ﹤0.01% 3036
2016
Q2 		$52K Buy
+1,006
New +$156K ﹤0.01% 3088

Other funds holding LPCN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

New York State Common Retirement Fund's LPCN Position: Q2 2017 in Review

New York State Common Retirement Fund sold out of Lipocine (LPCN) in Q2 2017, closing a stake of 1,006 shares — an estimated $67K sold.

New York State Common Retirement Fund first reported a position in LPCN in Q2 2016 and held it in 4 quarters. The position peaked at $76K in Q3 2016. 42 funds tracked by Wall St. Rank hold LPCN as of Q2 2017.

  • New York State Common Retirement Fund reported no remaining Lipocine position as of Q2 2017 after selling out during the quarter.
  • New York State Common Retirement Fund sold 1,006 Lipocine shares in Q2 2017, an estimated $67K.
  • New York State Common Retirement Fund first reported a position in Lipocine in Q2 2016 and held it in 4 quarters.
  • New York State Common Retirement Fund's Lipocine position peaked at $76K in Q3 2016.
  • 42 funds tracked by Wall St. Rank held Lipocine as of Q2 2017.

Based on New York State Common Retirement Fund's 13F filing for Q2 2017, filed 11 Aug 2017.